{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T15:01:09Z","timestamp":1784646069217,"version":"3.55.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":57,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key technological projects in Songjiang District, Shanghai","award":["No\uff1a2023SJKJGG99"],"award-info":[{"award-number":["No\uff1a2023SJKJGG99"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05259-8","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T20:03:09Z","timestamp":1779739389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CircLRIG1 inhibits the malignant phenotypes of colorectal cancer cells by inactivating the NF-\u03baB signaling through interaction with FUS"],"prefix":"10.1007","volume":"17","author":[{"given":"Qi","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenjia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"issue":"3","key":"5259_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5259_CR2","doi-asserted-by":"publisher","first-page":"p2019","DOI":"10.1007\/s12672-025-03791-7","volume":"16","author":"J Wu","year":"2025","unstructured":"Wu J, et al. Changing patterns of colorectal cancer in China between 2000 and 2016 based on tertiary hospital data. Discov Oncol. 2025;16(1):p2019.","journal-title":"Discov Oncol"},{"issue":"42","key":"5259_CR3","doi-asserted-by":"publisher","first-page":"e45315","DOI":"10.1097\/MD.0000000000045315","volume":"104","author":"MG Mastoi","year":"2025","unstructured":"Mastoi MG, et al. Advances in endoscopic techniques for early detection and treatment of gastrointestinal cancers: a systematic review. Med (Baltim). 2025;104(42):e45315.","journal-title":"Med (Baltim)"},{"key":"5259_CR4","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.suronc.2020.10.017","volume":"35","author":"N Akhtar-Danesh","year":"2020","unstructured":"Akhtar-Danesh N, et al. Uptake of minimally invasive surgery for early stage colorectal cancer and its effect on survival: a population-based study. Surg Oncol. 2020;35:540\u20136.","journal-title":"Surg Oncol"},{"issue":"1","key":"5259_CR5","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41591-022-02115-4","volume":"29","author":"D Kotani","year":"2023","unstructured":"Kotani D, et al. Molecular residual disease and efficacy of adjuvant chemotherapy in patients with colorectal cancer. Nat Med. 2023;29(1):127\u201334.","journal-title":"Nat Med"},{"issue":"4","key":"5259_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222\u201336.","journal-title":"Trends Pharmacol Sci"},{"issue":"Pt 1","key":"5259_CR7","first-page":"117495","volume":"243","author":"R Behera","year":"2025","unstructured":"Behera R, et al. Circular RNAs in colorectal cancer: emerging insights and future perspectives. Biochem Pharmacol. 2025;243(Pt 1):117495.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"5259_CR8","doi-asserted-by":"publisher","first-page":"101042","DOI":"10.1016\/j.repbio.2025.101042","volume":"25","author":"C Zhou","year":"2025","unstructured":"Zhou C, et al. Regulatory role of circRNAs in mammalian pregnancy. Reprod Biol. 2025;25(3):101042.","journal-title":"Reprod Biol"},{"key":"5259_CR9","doi-asserted-by":"publisher","first-page":"e18733","DOI":"10.7717\/peerj.18733","volume":"12","author":"S Yang","year":"2024","unstructured":"Yang S, Li D. The role of circRNA in breast cancer drug resistance. PeerJ. 2024;12:e18733.","journal-title":"PeerJ"},{"key":"5259_CR10","doi-asserted-by":"publisher","first-page":"1468363","DOI":"10.3389\/fonc.2024.1468363","volume":"14","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, et al. Circular RNA CDR1as\/ciRS-7- a novel biomarker in solid tumors. Front Oncol. 2024;14:1468363.","journal-title":"Front Oncol"},{"key":"5259_CR11","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/978-981-96-9428-0_11","volume":"1485","author":"SZ Abidin","year":"2025","unstructured":"Abidin SZ. Circular RNAs Regulate Transcription and Translation. Adv Exp Med Biol. 2025;1485:169\u201377.","journal-title":"Adv Exp Med Biol"},{"key":"5259_CR12","doi-asserted-by":"publisher","first-page":"156248","DOI":"10.1016\/j.prp.2025.156248","volume":"276","author":"J Zhang","year":"2025","unstructured":"Zhang J, et al. CircRBM33 facilitates colorectal cancer progression by regulating the miR-512-5p\/SLC1A5 axis. Pathol Res Pract. 2025;276:156248.","journal-title":"Pathol Res Pract"},{"issue":"1","key":"5259_CR13","doi-asserted-by":"publisher","first-page":"30931","DOI":"10.1038\/s41598-025-16450-2","volume":"15","author":"H Ge","year":"2025","unstructured":"Ge H, et al. Hsa_circ_0005571 promotes the proliferation and invasion of colorectal cancer cells. Sci Rep. 2025;15(1):30931.","journal-title":"Sci Rep"},{"issue":"1","key":"5259_CR14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41420-025-02478-w","volume":"11","author":"Y Zhou","year":"2025","unstructured":"Zhou Y, et al. QKI-induced circ_0001766 inhibits colorectal cancer progression and rapamycin resistance by miR-1203\/PPP1R3C\/mTOR\/Myc axis. Cell Death Discov. 2025;11(1):192.","journal-title":"Cell Death Discov"},{"issue":"1","key":"5259_CR15","doi-asserted-by":"publisher","first-page":"5494","DOI":"10.1038\/s41467-019-13532-4","volume":"10","author":"Q Li","year":"2019","unstructured":"Li Q, et al. LRIG1 is a pleiotropic androgen receptor-regulated feedback tumor suppressor in prostate cancer. Nat Commun. 2019;10(1):5494.","journal-title":"Nat Commun"},{"issue":"22","key":"5259_CR16","doi-asserted-by":"publisher","first-page":"2932","DOI":"10.1038\/onc.2015.345","volume":"35","author":"N Yokdang","year":"2016","unstructured":"Yokdang N, et al. LRIG1 opposes epithelial-to-mesenchymal transition and inhibits invasion of basal-like breast cancer cells. Oncogene. 2016;35(22):2932\u201347.","journal-title":"Oncogene"},{"issue":"1","key":"5259_CR17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13062-023-00446-x","volume":"19","author":"S Cheng","year":"2024","unstructured":"Cheng S, et al. Dysregulation and antimetastatic function of circLRIG1 modulated by miR-214-3p\/LRIG1 axis in bladder carcinoma. Biol Direct. 2024;19(1):20.","journal-title":"Biol Direct"},{"issue":"6","key":"5259_CR18","doi-asserted-by":"publisher","first-page":"630","DOI":"10.14740\/wjon2668","volume":"16","author":"RZ Sun","year":"2025","unstructured":"Sun RZ, et al. Analysis of the SH3-Domain Kinase Binding Protein 1 Predictive Model for Pancreatic Ductal Adenocarcinoma and CCCTC-Binding Factor Transcriptional Regulatory Study. World J Oncol. 2025;16(6):630\u201344.","journal-title":"World J Oncol"},{"issue":"1","key":"5259_CR19","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1186\/s12876-025-04423-8","volume":"25","author":"KJ Wu","year":"2025","unstructured":"Wu KJ, et al. Nitidine chloride inhibits colorectal cancer by targeting BUB1: mechanistic insights from molecular dynamics simulation, spatial transcriptomics, and single-cell RNA sequencing. BMC Gastroenterol. 2025;25(1):818.","journal-title":"BMC Gastroenterol"},{"issue":"6","key":"5259_CR20","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2015.02.014","volume":"160","author":"SJ Conn","year":"2015","unstructured":"Conn SJ, et al. The RNA binding protein quaking regulates formation of circRNAs. Cell. 2015;160(6):1125\u201334.","journal-title":"Cell"},{"issue":"3","key":"5259_CR21","doi-asserted-by":"publisher","first-page":"101049","DOI":"10.1016\/j.jbc.2021.101049","volume":"297","author":"W Jia","year":"2021","unstructured":"Jia W, et al. Fused in sarcoma regulates DNA replication timing and kinetics. J Biol Chem. 2021;297(3):101049.","journal-title":"J Biol Chem"},{"issue":"1","key":"5259_CR22","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10238-024-01525-7","volume":"25","author":"D Liu","year":"2024","unstructured":"Liu D, et al. FUS and METTL3 collaborate to regulate RNA maturation, preventing unfolded protein response and promoting gastric cancer progression. Clin Exp Med. 2024;25(1):15.","journal-title":"Clin Exp Med"},{"issue":"10","key":"5259_CR23","doi-asserted-by":"publisher","first-page":"e2204988","DOI":"10.1002\/advs.202204988","volume":"10","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Hypoxia-Induced FUS-circTBC1D14 Stress Granules Promote Autophagy in TNBC. Adv Sci (Weinh). 2023;10(10):e2204988.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"5259_CR24","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1186\/s40001-025-02734-w","volume":"30","author":"S Sadati","year":"2025","unstructured":"Sadati S, et al. NF-kappaB and apoptosis: colorectal cancer progression and novel strategies for treatment. Eur J Med Res. 2025;30(1):616.","journal-title":"Eur J Med Res"},{"issue":"1","key":"5259_CR25","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s11658-023-00448-7","volume":"28","author":"W Zheng","year":"2023","unstructured":"Zheng W, et al. CircRNF10-DHX15 interaction suppressed breast cancer progression by antagonizing DHX15-NF-kappaB p65 positive feedback loop. Cell Mol Biol Lett. 2023;28(1):34.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"5259_CR26","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s12935-025-03905-9","volume":"25","author":"S Li","year":"2025","unstructured":"Li S, et al. EIF4A3-induced circPRKAR1B promotes esophageal squamous cell carcinoma progression through binding PKM2 to regulate NF-kappaB induced CCL3 secretion. Cancer Cell Int. 2025;25(1):262.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"5259_CR27","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-024-02056-1","volume":"23","author":"Y Ji","year":"2024","unstructured":"Ji Y, et al. ESRP1-mediated biogenesis of circPTPN12 inhibits hepatocellular carcinoma progression by PDLIM2\/ NF-kappaB pathway. Mol Cancer. 2024;23(1):143.","journal-title":"Mol Cancer"},{"issue":"1","key":"5259_CR28","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s13287-025-04391-6","volume":"16","author":"L Lin","year":"2025","unstructured":"Lin L, et al. circ_0002456\/FUS interaction inhibits NF-kappaB signaling to attenuate DNA damage and inflammatory responses in hDPSCs. Stem Cell Res Ther. 2025;16(1):276.","journal-title":"Stem Cell Res Ther"},{"issue":"16","key":"5259_CR29","doi-asserted-by":"publisher","first-page":"13395","DOI":"10.1074\/jbc.M011176200","volume":"276","author":"H Uranishi","year":"2001","unstructured":"Uranishi H, et al. Involvement of the pro-oncoprotein TLS (translocated in liposarcoma) in nuclear factor-kappa B p65-mediated transcription as a coactivator. J Biol Chem. 2001;276(16):13395\u2013401.","journal-title":"J Biol Chem"},{"issue":"1","key":"5259_CR30","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1186\/s12967-025-07233-4","volume":"23","author":"BH Li","year":"2025","unstructured":"Li BH, et al. CircSipa1l1 modulates melanoma cell differentiation by activating the IGF2BP1-ARHGDIB axis and ERK signaling pathway. J Transl Med. 2025;23(1):1186.","journal-title":"J Transl Med"},{"issue":"1","key":"5259_CR31","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41419-025-08026-9","volume":"16","author":"S Li","year":"2025","unstructured":"Li S, et al. Circular SNX25 encoded radioresistance augmenter facilitates DNA damage repair in hepatocellular carcinoma by targeting BAG6-GET4 interaction. Cell Death Dis. 2025;16(1):734.","journal-title":"Cell Death Dis"},{"issue":"1","key":"5259_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12943-024-01971-7","volume":"23","author":"H Li","year":"2024","unstructured":"Li H, et al. CircHAS2 activates CCNE2 to promote cell proliferation and sensitizes the response of colorectal cancer to anlotinib. Mol Cancer. 2024;23(1):59.","journal-title":"Mol Cancer"},{"key":"5259_CR33","doi-asserted-by":"crossref","unstructured":"Quarshie JT et al. Cryptolepine Suppresses Colorectal Cancer Cell Proliferation, Stemness, and Metastatic Processes by Inhibiting WNT\/beta-Catenin Signaling. Pharmaceuticals (Basel). 2023;16(7):1026.","DOI":"10.3390\/ph16071026"},{"issue":"1","key":"5259_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s13046-022-02477-0","volume":"41","author":"L Wang","year":"2022","unstructured":"Wang L, et al. PCSK9 promotes the progression and metastasis of colon cancer cells through regulation of EMT and PI3K\/AKT signaling in tumor cells and phenotypic polarization of macrophages. J Exp Clin Cancer Res. 2022;41(1):303.","journal-title":"J Exp Clin Cancer Res"},{"issue":"Pt 2","key":"5259_CR35","doi-asserted-by":"publisher","first-page":"148879","DOI":"10.1016\/j.ijbiomac.2025.148879","volume":"333","author":"X Xie","year":"2025","unstructured":"Xie X, et al. CircSETD2 impairs hepatic lipid homeostasis in metabolic dysfunction-associated fatty liver disease by binding CPS1. Int J Biol Macromol. 2025;333(Pt 2):148879.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"5259_CR36","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/s41419-025-08107-9","volume":"16","author":"Y Liu","year":"2025","unstructured":"Liu Y, et al. Circular RNA FCHO2 promotes airway remodeling in COPD via regulating nuclear translocation of PTBP1 to repress the splicing of GRN pre-mRNA. Cell Death Dis. 2025;16(1):779.","journal-title":"Cell Death Dis"},{"issue":"4","key":"5259_CR37","doi-asserted-by":"publisher","first-page":"101383","DOI":"10.1016\/j.gendis.2024.101383","volume":"12","author":"L Li","year":"2025","unstructured":"Li L, et al. Expanded insights into the mechanisms of RNA-binding protein regulation of circRNA generation and function in cancer biology and therapy. Genes Dis. 2025;12(4):101383.","journal-title":"Genes Dis"},{"key":"5259_CR38","doi-asserted-by":"publisher","first-page":"35195","DOI":"10.1038\/srep35195","volume":"6","author":"A Yamaguchi","year":"2016","unstructured":"Yamaguchi A, Takanashi K. FUS interacts with nuclear matrix-associated protein SAFB1 as well as Matrin3 to regulate splicing and ligand-mediated transcription. Sci Rep. 2016;6:35195.","journal-title":"Sci Rep"},{"key":"5259_CR39","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/1476-4598-12-86","volume":"12","author":"B Hoesel","year":"2013","unstructured":"Hoesel B, Schmid JA. The complexity of NF-kappaB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.","journal-title":"Mol Cancer"},{"issue":"8","key":"5259_CR40","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun SC. NF-kappaB in inflammation and cancer. Cell Mol Immunol. 2025;22(8):811\u201339.","journal-title":"Cell Mol Immunol"},{"issue":"12","key":"5259_CR41","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/sj.onc.1207332","volume":"23","author":"T Lu","year":"2004","unstructured":"Lu T, et al. Secretion of cytokines and growth factors as a general cause of constitutive NFkappaB activation in cancer. Oncogene. 2004;23(12):2138\u201345.","journal-title":"Oncogene"},{"issue":"1","key":"5259_CR42","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s13046-017-0610-5","volume":"36","author":"YC Zhang","year":"2017","unstructured":"Zhang YC, et al. PAK5-mediated phosphorylation and nuclear translocation of NF-kappaB-p65 promotes breast cancer cell proliferation in vitro and in vivo. J Exp Clin Cancer Res. 2017;36(1):146.","journal-title":"J Exp Clin Cancer Res"},{"key":"5259_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jim.2015.03.018","volume":"423","author":"O Maguire","year":"2015","unstructured":"Maguire O, O\u2019Loughlin K, Minderman H. Simultaneous assessment of NF-kappaB\/p65 phosphorylation and nuclear localization using imaging flow cytometry. J Immunol Methods. 2015;423:3\u201311.","journal-title":"J Immunol Methods"},{"issue":"3","key":"5259_CR44","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jphs.2018.07.003","volume":"137","author":"K Takakura","year":"2018","unstructured":"Takakura K, et al. Inhibition of nuclear factor-kappaB p65 phosphorylation by 3,4-dihydroxybenzalacetone and caffeic acid phenethyl ester. J Pharmacol Sci. 2018;137(3):248\u201355.","journal-title":"J Pharmacol Sci"},{"key":"5259_CR45","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1478-811X-11-73","volume":"11","author":"D Mladenova","year":"2013","unstructured":"Mladenova D, et al. Sulindac activates NF-kappaB signaling in colon cancer cells. Cell Commun Signal. 2013;11:73.","journal-title":"Cell Commun Signal"},{"issue":"9","key":"5259_CR46","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/s41419-021-03794-6","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang X, et al. Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt\/beta-catenin pathway. Cell Death Dis. 2021;12(9):802.","journal-title":"Cell Death Dis"},{"key":"5259_CR47","doi-asserted-by":"publisher","first-page":"112436","DOI":"10.1016\/j.exger.2024.112436","volume":"191","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. LncRNA NEAT1 promotes MPP+ induced injury of PC12 cells and accelerates the progression of Parkinson\u2019s disease in mice through FUS mediated inhibition of PI3K\/AKT\/mTOR signalling pathway. Exp Gerontol. 2024;191:112436.","journal-title":"Exp Gerontol"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05259-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05259-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T14:01:53Z","timestamp":1784642513000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05259-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5259"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05259-8","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study involving human tissues was approved by the Ethics Committee of Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (Approval No. 2024-31), ensuring that all procedures strictly adhered to the ethical principles outlined in the Declaration of Helsinki. All animal procedures were approved by the Animal Ethics Committee of Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (Approval No. 2024-31). According to the Guidelines for Ethical Review of Welfare of Chinese Experimental Animals and the requirements of the Ethics Committee of Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, the weight of the tumor should not exceed 10% of the normal body weight, and the diameter of the tumor on the body surface of adult mice should not exceed 20\u00a0mm in any direction. This animal experiment was terminated by ethical approval when the committee confirmed that the maximum tumor size\/burden was not exceeded.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients who participated in this study signed informed consent before surgery for the use of their specimens and disease information for future research. For patients with impaired decision-making capacity, consent was obtained from legally authorized representatives in accordance with approved surrogate consent procedures. For participants under 18 years of age, informed consent was obtained from their parent or legal guardian, and assent was obtained from the participants whenever appropriate.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1052"}}